Gilead (GILD) Files BLA for Bulevirtide for Hepatitis Delta Virus

Published on November 22, 2021

Gilead (GILD) submits a biologics license application to the FDA for bulevirtide for the treatment of chronic hepatitis delta virus infection in adults with compensated liver disease.

Continue reading on website
Other news

Has Aflac (AFL) Outpaced Other Finance Stocks This Year?

November 22, 2021
Here is how Aflac (AFL) and Franklin Resources (BEN) have performed compared to their sector so far this year.

What procedures are needed to set up a company and start operating in Mexico?

November 22, 2021
On paper and in theory, it is not that difficult to create a business in the Aztec Nation, as the process consists of six steps.